Literature DB >> 10650179

Relaxation of rabbit lower urinary tract smooth muscle by nitric oxide and carbon monoxide: modulation by hydrogen peroxide.

K M Naseem1, F H Mumtaz, C S Thompson, M E Sullivan, M A Khan, R J Morgan, D P Mikhailidis, K R Bruckdorfer.   

Abstract

Recent studies suggest that the body produces two gaseous messengers, nitric oxide (NO) and carbon monoxide (CO), both of which activate soluble guanylyl cyclase and thus modulate the activity of smooth muscle cells. In the present study, the effects of NO and CO on the smooth muscle of the lower urinary tract were compared. In addition, the modulation of tissue NO- and CO-induced relaxation by hydrogen peroxide was examined. NO, produced endogenously by electrical field stimulation (EFS) or applied exogenously as a solution, induced a concentration-dependent relaxation of rabbit cavernosal and urethral smooth muscle strips, but not of bladder tissues. The cavernosal tissue was found to be three times more sensitive to the actions of NO than the urethra. CO also induced relaxation of both tissue types, but with no apparent difference in sensitivity between the tissues. However, CO was much less potent than NO with respect to smooth muscle relaxation. The mechanism of action of the two mediators was cyclic guanosine monophosphate (cGMP)-dependent, as evidenced by enhanced formation of cGMP and inhibition of relaxation by the guanylyl cyclase inhibitor, oxadiazoloquinoxaline-1-one (ODQ.) The data suggests that NO is the dominant messenger in these tissues, but does not exclude a role for CO. In the presence of hydrogen peroxide, the relaxation responses induced by both NO and CO were significantly increased, regardless of tissue type. The mechanism for this effect is unclear, but evidence points to a requirement for the activation of guanylyl cyclase and enhanced formation of cGMP, since potentiation by the peroxide was blocked by a specific guanylyl cyclase inhibitor. We suggest that H(2)O(2) may play a positive role in the amplification or NO and CO-mediated responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10650179     DOI: 10.1016/s0014-2999(99)00818-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Lipopolysaccharide reduces urethral smooth muscle contractility via cyclooxygenase activation.

Authors:  Fabiano B Calmasini; Eduardo C Alexandre; Mariana G Oliveira; Fábio H Silva; António G Soares; Soraia K P Costa; Edson Antunes
Journal:  J Physiol Biochem       Date:  2021-05-21       Impact factor: 4.158

Review 3.  Lower urinary tract physiology and pharmacology.

Authors:  M E DiSanto; A J Wein; S Chacko
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

4.  Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation.

Authors:  Muammer Kendirci; Emad Salem; Wayne Jg Hellstrom
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.